BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lai WF, Wong WT. Progress and trends in the development of therapies for Hutchinson-Gilford progeria syndrome. Aging Cell 2020;19:e13175. [PMID: 32596971 DOI: 10.1111/acel.13175] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang SL, Lin SZ, Zhou YQ, Wang WQ, Li JY, Wang C, Pang QM. Clinical manifestations and gene analysis of Hutchinson-Gilford progeria syndrome: A case report. World J Clin Cases 2022; 10(15): 5018-5024 [DOI: 10.12998/wjcc.v10.i15.5018] [Reference Citation Analysis]
2 Mosevitsky MI. Progerin and Its Role in Accelerated and Natural Aging. Mol Biol 2022;56:125-46. [DOI: 10.1134/s0026893322020091] [Reference Citation Analysis]
3 Macicior J, Marcos-Ramiro B, Ortega-Gutiérrez S. Small-Molecule Therapeutic Perspectives for the Treatment of Progeria. Int J Mol Sci 2021;22:7190. [PMID: 34281245 DOI: 10.3390/ijms22137190] [Reference Citation Analysis]
4 Benedicto I, Dorado B, Andrés V. Molecular and Cellular Mechanisms Driving Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome: Lessons Learned from Animal Models. Cells 2021;10:1157. [PMID: 34064612 DOI: 10.3390/cells10051157] [Reference Citation Analysis]
5 Koblan LW, Erdos MR, Wilson C, Cabral WA, Levy JM, Xiong ZM, Tavarez UL, Davison LM, Gete YG, Mao X, Newby GA, Doherty SP, Narisu N, Sheng Q, Krilow C, Lin CY, Gordon LB, Cao K, Collins FS, Brown JD, Liu DR. In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice. Nature 2021;589:608-14. [PMID: 33408413 DOI: 10.1038/s41586-020-03086-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 37.0] [Reference Citation Analysis]
6 Warnecke A, Giesemann A. Embryology, Malformations, and Rare Diseases of the Cochlea. Laryngorhinootologie 2021;100:S1-S43. [PMID: 34352899 DOI: 10.1055/a-1349-3824] [Reference Citation Analysis]
7 Lai WF, Wong WT. Progress and trends in the development of therapies for Hutchinson-Gilford progeria syndrome. Aging Cell 2020;19:e13175. [PMID: 32596971 DOI: 10.1111/acel.13175] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
8 González-Dominguez A, Montañez R, Castejón-Vega B, Nuñez-Vasco J, Lendines-Cordero D, Wang C, Mbalaviele G, Navarro-Pando JM, Alcocer-Gómez E, Cordero MD. Inhibition of the NLRP3 inflammasome improves lifespan in animal murine model of Hutchinson-Gilford Progeria. EMBO Mol Med 2021;13:e14012. [PMID: 34448355 DOI: 10.15252/emmm.202114012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]